|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.23 EUR | -1.52% |
|
-7.65% | -9.07% |
| 04:59pm | Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study | RE |
| 06/03 | Brazil's EMS purchases Sanofi's Medley in deal worth over $500 million | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- SAN Stock
- Consensus Sanofi
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition